Bours, C. C. A. H. http://orcid.org/0000-0001-9760-3059
Bakker-Huvenaars, M. J.
Tramper, J.
Bielczyk, N.
Scheepers, F.
Nijhof, K. S.
Baanders, A. N.
Lambregts-Rommelse, N. N. J.
Medendorp, P.
Glennon, J. C.
Buitelaar, J. K.
Funding for this research was provided by:
National Initiative Brain & Cognition (056-24-011, 056-24-014)
AGGRESSOTYPE (602805)
MATRICS (603016)
EU-AIMS (115300)
Article History
Received: 20 December 2017
Accepted: 22 May 2018
First Online: 19 June 2018
Compliance with ethical standards
:
: CC.A.H. Bours, M.J. Bakker-Huvenaars, J. Tramper, N. Bielczyk, A. N. Baanders, K.S. Nijhof, N.N.J. Lambregts-Rommelse, P. Medendorp, and F. Scheepers declared to have no conflicts of interest. J.C. Glennon has been in the past 3 years a consultant to Boehringer Ingelheim GmbH on matters unrelated to this paper. Jan K Buitelaar has been in the past 3 years a consultant to/member of advisory board of/and/or speaker for Janssen Cilag BV, Eli Lilly, Lundbeck, Shire, Roche, Novartis, Medice, and Servier. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, and royalties.